Position in KRYS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$3,716
New position
Shares Held
10
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 90 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aspect Partners, LLC holds $47,512 across 14 Biotechnology names. KRYS ranks #6 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21 | $10,431 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
200 | $7,078 | |
| 3 | DYN |
Dyne Therapeutics, Inc.
|
233 | $5,174 | |
| 4 | TLX |
Telix Pharmaceuticals Ltd
|
401 | $4,623 | |
| 5 | LEGN |
Legend Biotech Corp
|
160 | $4,620 | |
| 6 | KRYS |
Krystal Biotech, Inc.
This page
|
10 | $3,716 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
59 | $3,375 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5 | $3,117 |
All Filings in KRYS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,716 | 10 | Shares | Sole | 2026-07-16 | |
| No filing history on record for this holder in this stock. | ||||||